Skip to main content

CITADEL ADVISORS LLC

Position in RAPP — Rapport Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in RAPP

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$3,435,358
+$3,189,635 QoQ
Shares Held
82,442
+917.9% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 159 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RAPP Over Time

Shares Held

Position Value (USD)

Derivatives in RAPP

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$512,746
PutShares
16,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. RAPP ranks #162 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RAPP

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,435,358 82,442
2025-12-31 $245,723 8,099
2025-12-31 $512,746 16,900
2025-09-30 $1,027,620 34,600
2025-09-30 $412,830 13,900
2025-09-30 $3,114,876 104,878
2025-03-31 $2,501,622 249,414
2025-03-31 $10,030 1,000
2025-03-31 $20,060 2,000
2024-12-31 $8,647,504 487,458
2024-09-30 $9,983,139 487,458
2024-06-30 $13,780,573 592,458